These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 2791497)
1. Antimicrobial activity of lomefloxacin (NY-198, SC 47111) against bacterial strains from Venezuela. Torres JR Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):41S-43S. PubMed ID: 2791497 [TBL] [Abstract][Full Text] [Related]
2. In vitro activity of lomefloxacin (SC 47111 or NY-198), a new quinolone antimicrobial, against clinical isolates of common pathogens. Sonstein SA; Dahlgren J Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):21S-28S. PubMed ID: 2791494 [TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activity of lomefloxacin, a difluoro-quinolone. Robbins MJ; Baskerville AJ; Sanghrajka M; Mumtaz G; Felmingham D; Ridgway GL; Grüneberg RN Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):65S-76S. PubMed ID: 2791500 [TBL] [Abstract][Full Text] [Related]
4. Lomefloxacin, a new fluoroquinolone. Studies on in vitro antimicrobial spectrum, potency, and development of resistance. Aldridge KE; Henderberg A; Gebbia K; Schiro DD; Janney A; Sanders CV Diagn Microbiol Infect Dis; 1989; 12(3):221-33. PubMed ID: 2791485 [TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro activity of lomefloxacin (SC 47111 or NY-198) against fresh clinical bacterial isolates. Wright DN; Saxon B; Matsen JM Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):7S-11S. PubMed ID: 2791501 [TBL] [Abstract][Full Text] [Related]
6. A ten-laboratory study of lomefloxacin (NY-198 or SC 47111) antimicrobial activity in Argentina. Bianchini HN; Sarachian B; Fernandez A; Paolasso R; Kaufman C; Notario R; Porven G; Ingaramo RA; Perez S; Ferrero SM Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):45S-50S. PubMed ID: 2676328 [TBL] [Abstract][Full Text] [Related]
7. Lomefloxacin (SC 47111 or NY-198), a new difluorinated quinolone: comparison of the in vitro activity with other broad spectrum antimicrobials against Enterobacteriaceae, Acinetobacter spp, Aeromonas spp, and Pseudomonas aeruginosa. Aldridge KE; Henderberg A; Sanders CV Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):1S-6S. PubMed ID: 2507219 [TBL] [Abstract][Full Text] [Related]
8. Lomefloxacin, a new difluoroquinolone: in vitro activity against gram-positive and gram-negative bacteria. Hoban D; Grabowski M; Koss J; Weselowski V Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):77S-82S. PubMed ID: 2791502 [TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of lomefloxacin activity in Colombia. Trujillo H; Mejia GI; Castrillon L; Gomez C Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):51S-52S. PubMed ID: 2791498 [TBL] [Abstract][Full Text] [Related]
10. In vitro activity of lomefloxacin against multiply resistant Pseudomonas aeruginosa, Enterobacter cloacae, and Staphylococcus epidermidis. DiVincenzo CA; Shatzer KL; Venezio FR Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):13S-16S. PubMed ID: 2507220 [TBL] [Abstract][Full Text] [Related]
11. In vitro activity of lomefloxacin (NY-198 or SC 47111). Shah PM; Müller S; Kipp J; Stille W Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):97S-101S. PubMed ID: 2791506 [TBL] [Abstract][Full Text] [Related]
12. In vitro activity of lomefloxacin, a difluorinated quinolone, compared with other antimicrobials. Qadri SM; Lee GC; Ellis ME Chemotherapy; 1991; 37(3):166-74. PubMed ID: 1889304 [TBL] [Abstract][Full Text] [Related]
13. Lomefloxacin (SC-47111 or NY-198). Comparative antimicrobial activity against 2002 clinical isolates from hospitals in Mexico City. Durazo F; Resano F; Gonzalez MA Diagn Microbiol Infect Dis; 1990; 13(1):71-5. PubMed ID: 2331854 [TBL] [Abstract][Full Text] [Related]
14. Multicenter in vitro evaluation of lomefloxacin (NY-198, SC-47111), including tests against nearly 7,000 bacterial isolates and preliminary recommendations for susceptibility testing. Jones RN; Aldridge KE; Barry AL; Fuchs PC; Gerlach EH; Pfaller MA; Washington JA Diagn Microbiol Infect Dis; 1988 Aug; 10(4):221-40. PubMed ID: 3072151 [TBL] [Abstract][Full Text] [Related]
15. [In vitro evaluation of lomefloxacin]. Dette GA; Knothe H Arzneimittelforschung; 1989 Aug; 39(8):832-5. PubMed ID: 2818672 [TBL] [Abstract][Full Text] [Related]
16. In vitro antimicrobial activity and postantibiotic effect of lomefloxacin, a new difluoroquinolone. Molinari G; Bandelloni R; Paglia P; Debbia E; Schito GC Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):53S-56S. PubMed ID: 2791499 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of in vitro antimicrobial activity of lomefloxacin against staphylococci, enterococci, Enterobacteriaceae, and Pseudomonas aeruginosa. Rossolini GM; Valentini S; Satta G Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):57S-64S. PubMed ID: 2507221 [TBL] [Abstract][Full Text] [Related]
18. In-vitro activity of lomefloxacin (SC-47111) and other quinolones. Sun ZM; Maskell JP; Sehgal SC; Williams JD Infection; 1989; 17(3):165-7. PubMed ID: 2737760 [TBL] [Abstract][Full Text] [Related]
19. Bactericidal activity of lomefloxacin SC 47111 (NY-198) and ciprofloxacin against selected pathogens. Stratton CW; Weeks LS Diagn Microbiol Infect Dis; 1989; 12(3 Suppl):29S-34S. PubMed ID: 2791495 [TBL] [Abstract][Full Text] [Related]
20. Lomefloxacin: microbiologic assessment and unique properties. Mayer KH; Ellal JA Am J Med; 1992 Apr; 92(4A):58S-62S. PubMed ID: 1316073 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]